KMA Holding, Inc. (MCDA) Research

KMA Holding, Inc., operating in the United States, specializes in the production of medical diagnostic solutions. Its primary offerings include at-home test kits designed for both human and pet use, as well as mobile hospital units for emergency response. The company's diagnostic kits are engineered to identify various health conditions, such as cancer, by analyzing biological samples like blood, saliva, urine, hair, and other bodily fluids. For human consumers, their home screening product range covers detection for substance abuse, sexually transmitted infections, a variety of infectious diseases, tumor markers, and fertility indicators. Similarly, pet owners can utilize at-home medical tests for conditions including cancer, diabetes, and Lyme disease. In addition to diagnostics, KMA Holding also provides critical mobile emergency response hospital units. These units are equipped to deliver temporary life support, offer essential medical and pharmaceutical supplies and services, and maintain secure wireless communication capabilities during crisis situations. Established in 2000, the company was initially known as Macada Holding, Inc. before officially changing its name to KMA Holding, Inc. in March 2011. Its corporate headquarters are located in Pompano Beach, Florida.

Open KMA Holding, Inc. (MCDA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.